Heterogeneity of Treatment Effects: Implications for Guidelines, Payment, and Quality Assessment
- 1 April 2007
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 120 (4) , S3-S9
- https://doi.org/10.1016/j.amjmed.2007.02.002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Calcium plus Vitamin D and the Risk of FracturesNew England Journal of Medicine, 2006
- Glucosamine and Chondroitin Sulfate for Knee OsteoarthritisNew England Journal of Medicine, 2006
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsNew England Journal of Medicine, 2006
- The Charisma of Subgroups and the Subgroups of CHARISMANew England Journal of Medicine, 2006
- Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysisBMC Medical Research Methodology, 2006
- Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee OsteoarthritisNew England Journal of Medicine, 2006
- Calcium plus Vitamin D Supplementation and the Risk of FracturesNew England Journal of Medicine, 2006
- Evidence‐Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with AveragesThe Milbank Quarterly, 2004
- Pharmacogenetics in the Laboratory and the ClinicNew England Journal of Medicine, 2003
- Clinical application of pharmacogeneticsTrends in Molecular Medicine, 2001